Überblick


Anthony Paronneau advises clients on all aspects of corporate and business law, with a particular focus on pharmaceutical, medical device, biotech and healthcare industries.

Mehr anzeigen

Ausgewählte Referenzmandate


  • Represented Vivet Therapeutics, a French biotech, on its exclusive option to be acquired by and its sale of a 15% ownership stake to Pfizer.
  • Represented Servier on its acquisition of Symphogen.
  • Represented Arterial Remodeling Technologies (ART), a French medtech developing an active bioabsorbable stent for the treatment of coronary disease, on its structured sale to the Japanese group Terumo Corporation.

Mehr anzeigen

Auszeichnungen


  • Legal 500, 2020, Healthcare & Life Sciences-France
  • Décideurs Juridiques, Capital Investments: Operational Risk, Excellent, 2020
  • Décideurs Juridiques, Health, Pharma and Biotechnology: Digital Health, Forte Notoriété, 2019
  • Décideurs Juridiques, Health, Pharma and Biotechnology: Regulatory, Excellent, 2019

Mehr anzeigen

Qualifikation


Education
HEC Paris School of Management, Graduate
Université Paris – Sud 11, DEA, Private Law, 2003
Université Paris – Sud 11, Maîtrise, Business Law, 2001

Admissions
Paris

Mehr anzeigen

Anthony Paronneau

Einblicke & Events / Medien

Paris, France / Externe Vorträge / April 4, 2018

San Francisco, California / McDermott Event / January 10, 2017

Veröffentlichungen / February 23, 2015

1